Profil
Dr. Amanda Hayward is a Senior VP & Head-Business Development at Rallybio Corp.
Dr. Hayward was previously employed as a Chairman by Hoba Therapeutics ApS, a Senior Vice President by Scheer & Co., Inc., a Partner by Baxalta Ventures, a Managing Director by Connecticut Innovations, Inc., and a Chief Financial Officer by Renetx Bio, Inc. She also served on the board at Optherion, Inc. She received her undergraduate degree from The University of Sheffield and a doctorate degree from Texas Tech University Health Sciences Center.
Postes actifs de Amanda Hayward
| Sociétés | Poste | Début |
|---|---|---|
| RALLYBIO CORPORATION | Corporate Officer/Principal | 01/10/2019 |
Anciens postes connus de Amanda Hayward
| Sociétés | Poste | Fin |
|---|---|---|
Hoba Therapeutics ApS
Hoba Therapeutics ApS BiotechnologyHealth Technology Engages in research and development of therapeutics for pain, hearing loss and sensory neuron disorders | Président | 01/03/2024 |
Scheer & Co., Inc.
Scheer & Co., Inc. Investment ManagersFinance Scheer invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and healthcare industries. It provides financing for early stage capital requirements. | Analyste en capital-investissement | 25/05/2010 |
Baxalta Ventures
Baxalta Ventures Investment ManagersFinance Baxalta Ventures invests in healthcare companies located in the United States. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Connecticut Innovations, Inc.
Connecticut Innovations, Inc. Investment ManagersFinance CI invests in companies located in the US, primarily in Connecticut. The firm targets companies operating in the fields of Greentech, Consumer, Healthcare, Venture Funds, Technology. It provides debt and equity financing for seed and early stage capital requirements with an investment size up to $500,000. | Private Equity Investor | - |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Directeur Financier/CFO | - |
Formation de Amanda Hayward
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Connecticut Innovations, Inc.
Connecticut Innovations, Inc. Investment ManagersFinance CI invests in companies located in the US, primarily in Connecticut. The firm targets companies operating in the fields of Greentech, Consumer, Healthcare, Venture Funds, Technology. It provides debt and equity financing for seed and early stage capital requirements with an investment size up to $500,000. | Finance |
Optherion, Inc.
Optherion, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops disease modifying therapeutics | Health Technology |
The University of Sheffield
The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scheer & Co., Inc.
Scheer & Co., Inc. Investment ManagersFinance Scheer invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and healthcare industries. It provides financing for early stage capital requirements. | Finance |
Texas Tech University Health Sciences Center
Texas Tech University Health Sciences Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxalta Ventures
Baxalta Ventures Investment ManagersFinance Baxalta Ventures invests in healthcare companies located in the United States. It provides financing for early stage capital requirements. | Finance |
Hoba Therapeutics ApS
Hoba Therapeutics ApS BiotechnologyHealth Technology Engages in research and development of therapeutics for pain, hearing loss and sensory neuron disorders | Health Technology |
Rallybio Corp.
Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
















